CHRONIC RHINOSINUSITIS WITH NASAL POLYPS (CRSWNP)
Clinical trials for CHRONIC RHINOSINUSITIS WITH NASAL POLYPS (CRSWNP) explained in plain language.
Never miss a new study
Get alerted when new CHRONIC RHINOSINUSITIS WITH NASAL POLYPS (CRSWNP) trials appear
Sign up with your email to follow new studies for CHRONIC RHINOSINUSITIS WITH NASAL POLYPS (CRSWNP), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Tracking a new Treatment's Real-World impact on nasal polyps and asthma
Disease control Recruiting nowThis study aims to see how well the drug tezepelumab works for adults with chronic nasal polyps, with or without asthma, in real-world medical settings. It will follow 110 participants in Russia for about a year to measure changes in their nasal symptoms, asthma control, and over…
Matched conditions: CHRONIC RHINOSINUSITIS WITH NASAL POLYPS (CRSWNP)
Sponsor: AstraZeneca • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New injection tested to shrink stubborn nasal polyps
Disease control Recruiting nowThis study is testing whether adding lebrikizumab, an injectable medication, to standard nasal sprays helps people with chronic sinusitis and nasal polyps. It will involve about 510 participants and last around 18 months. The main goals are to see if the treatment reduces feeling…
Matched conditions: CHRONIC RHINOSINUSITIS WITH NASAL POLYPS (CRSWNP)
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New injection aims to shrink stubborn nasal polyps
Disease control Recruiting nowThis study is testing an investigational injection called TQC2731 for adults with chronic sinusitis and nasal polyps. The goal is to see if the injection can safely reduce polyp size and nasal congestion over 24 weeks compared to a placebo. About 246 participants will be randomly…
Matched conditions: CHRONIC RHINOSINUSITIS WITH NASAL POLYPS (CRSWNP)
Phase: PHASE3 • Sponsor: Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
Shine a light, skip the surgery? new device aims to transform nasal polyp diagnosis
Diagnosis Recruiting nowThis study is testing a new, non-invasive device that uses safe light to instantly identify a hard-to-treat type of nasal polyp. Currently, diagnosing this type requires a tissue sample taken during surgery, which can delay treatment. The goal is to see if this quick, in-office t…
Matched conditions: CHRONIC RHINOSINUSITIS WITH NASAL POLYPS (CRSWNP)
Phase: NA • Sponsor: The Affiliated Hospital of Qingdao University • Aim: Diagnosis
Last updated Mar 18, 2026 14:41 UTC